I-Sodium Methanesulfinate CAS 20277-69-4 Ubunyulu > 96.0% IFactory High Purity
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili we-Sodium Methanesulfinate (CAS: 20277-69-4) enomgangatho ophezulu.I-Ruifu Chemical inokubonelela ngenkonzo yehlabathi jikelele, ixabiso elikhuphisanayo, inkonzo egqwesileyo, encinci kunye nezixa ezininzi ezikhoyo.Thenga iSodium Methanesulfinate,Please contact: alvin@ruifuchem.com
Igama leMchiza | Isodium methanesulfinate |
Izithethantonye | Methanesulfinic Acid Sodium iTyuwa |
Inombolo yeCAS | 20277-69-4 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-CH5NaO2S |
Ubunzima beMolekyuli | 104.1 |
Indawo yokunyibilika | 222.0~226.0℃(dec.) (lit.) |
Ukunyibilika kwamanzi | Inyibilika emanzini |
Inovakalelo | Ubuthathaka boMoya kunye neHygroscopic |
I-COA kunye ne-MSDS | Iyafumaneka |
Imvelaphi | Shanghai, China |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystal oMhlophe okanye oMhlophe |
Ubunyulu | >96.0% |
Ilahleko ekomisweni | <1.00% |
I-Infrared Spectrum | Iyahambelana noLwakhiwo |
Proton NMR Spectrum | Iyahambelana noLwakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | abaPhakathi bamayeza;I-Organic Synthesis |
Iimpawu ezinobungozi | Xn - Inobungozi |
Iikhowudi zoMngcipheko | I-R22 - Iyingozi xa iginyiwe |
I-R20/21/22 - Iyingozi ngokuphefumla, xa udibana nolusu naxa uginyiwe. | |
Inkcazelo yoKhuseleko | S36/37 -Nxiba iimpahla ezifanelekileyo zokukhusela kunye neeglavu. |
I-S24/25 - Gwema ukudibana nolusu kunye namehlo. | |
Izazisi ze-UN | 2811 |
WGK eJamani | 3 |
Iqela lokuPakisha | III |
I-Shanghai Ruifu Chemical Co., Ltd. unikezelo lwezorhwebo lwe-Sodium Methanesulfinate (CAS: 20277-69-4).Yinto ebalulekileyo ye-pharmaceutical intermediate, enokusetyenziswa kwi-prodcution ye-API (CAS 231277-92-2) kunye (i-CAS 388082-78-8) i-API okanye enye i-intermediates.(CAS 388082-78-8), Ilungu elitsha leklasi ye-4-anilinoquinazoline ye-RTK inhibitors (RTKIs), yasungulwa njengonyango lomlomo lomhlaza webele.Inobudlelwane obubini be-EGFR kunye ne-HER2 tyrosine kinases.Ibonakaliswe ngokudibeneyo ne-Capecitabine ekunyangeni izigulane ezinomhlaza webele ophezulu okanye we-metastatic abane-tumor overexpress HER2 kwaye abaye bafumana unyango lwangaphambili olubandakanya i-anthracycline, i-taxane, kunye ne-trastuzumab.